<DOC>
	<DOC>NCT01676090</DOC>
	<brief_summary>To determine the normative ranges of the Insulin-like Growth Factor 1 (IGF-1), Insulin-like growth factor-binding protein 3 (IGFBP-3), Acid-Labile Subunit (ALS) according to age, sex and pubertal stage of a healthy paediatric Spanish population.</brief_summary>
	<brief_title>IGF-1, IGFBP3, ALS Normative Ranges in Healthy Pediatric Spanish Population</brief_title>
	<detailed_description />
	<criteria>Children of either sex of Caucasian parents Age: newborns up to and including 18 years of age Length/height, weight and body mass index (BMI) within the mean +/ 2SD (Standard Deviation) and in accordance with the growth charts of the 2010 Spanish crosssectional growth study (Carrascosa Lezcano et al 2010) Signed consent by at least one parent or legal guardian (if subject is ≤18 years) and by subject if ≥12 years Early or advanced puberty (pubertal signs: between 8 and 9 years old in girls, and between 9 and 10 years old in boys), or delayed puberty (no puberty onset in ≥ 13 yearold girls, and in ≥ 14 yearold boys) Chronic diseases including, but not limited to, endocrinologic diseases, chromosomal diseases, chronic diseases of renal, hepatic and/or cardiac aetiology, and tumour processes An acute disease during the last two weeks prior to recruitment Any clinically significant outofrange lab value Healthy paediatric volunteers who are under medical treatment (contraception permitted) A family history of short stature (either parent &lt; P3) Children born small for gestational age (birth weight, length, or head circumference &lt; P10) Adopted children or conceived through in vitro fertilization ( IVF ) Subjects who are unwilling or unable in the opinion of the investigator or sponsor to undergo all the study procedures</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>